Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine.
Clinical trial NCT04990466 · WITHDRAWN
Trial details
- NCT number
- NCT04990466
- Sponsor
- NeuroRx, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2021-12-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.